Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 Study of BMS747158 (Flurpiridaz F 18) Cardiac PET Imaging Protocols
NCT00849108Phase 2Completed
- Sponsor
- Lantheus Holdings, Inc.
- Start
- Jan 2009
- Primary completion
- Jun 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Flurpiridaz F 18 in coronary artery disease (CAD), sponsored by Lantheus Holdings, Inc.. Started Jan 2009; status: completed.
02
Drugs
Flurpiridaz F 18
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT00849108.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00849108.